HOME Top Market Reports Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023

Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: March 2018
Report Code: BT 4628

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The stem cell assay market was valued at USD 660.9 Million in 2017 and is expected to reach USD 1,978.7 Million by 2023, at a CAGR of 20.1%. The base year for this study is 2017 and the forecast period is 2018–2023.

The objectives of this study are as follows:

  • To define, describe, segment, and forecast the stem cell assays market by type, cell type, product & service, application, end user, and region
  • To forecast the revenue of the market segments of North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, and opportunities affecting market growth
  • To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the stem cell assays market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by type, cell type, product & service, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as Association of Stem Cell Banks of India (ASBI), American Association for the Advancement of Science (AAAS), Association of the British Pharmaceutical Industry (ABPI), Australasian Society for Stem Cell Research (ASSCR), American Medical Association (AMA), and many others, have been used to identify and collect information useful for this extensive commercial study of the stem cell assay market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information and to assess prospects of the stem cell assay market. The breakdown of profiles of primaries is shown in the figure below:

Stem Cell Assay Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the stem cell assay market include Merck (Germany), Thermo Fisher Scientific (US), GE Healthcare (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Promega Corporation (US), Cell Biolabs (US), PerkinElmer (US), Miltenyi Biotec (Germany), HemoGenix (US), Bio-Techne Corporation (US), STEMCELL Technologies (Canada), and Cellular Dynamics International (US).

Target Audience for this Report:

  • Manufacturers and vendors of stem cell assays
  • Research associations involved in stem cell research
  • Various research and consulting firms
  • Distributors of stem cell assays
  • Contract research manufacturers of stem cell assays
  • Healthcare institutions
  • Research institutes

Scope of the Report:

This report categorizes the stem cell assay market into the following segments:

By Type

  • Viability/Cytotoxicity
  • Isolation & Purification
  • Cell Identification
  • Proliferation
  • Differentiation
  • Function
  • Apoptosis

By Cell Type

  • Adult Stem Cells
    • Mesenchymal stem cells (MSCs)
    • Induced pluripotent stem cells (iPSCs)
    • Hematopoietic stem cells (HSCs)
    • Umbilical cord stem cells
    • Neural stem cells (NSCs)
  • Human embryonic stem cells (hESCs)

By Product & Service

  • Instruments
    • Flow Cytometers
    • Microelectrode Arrays
    • Cell Imaging Systems
    • Automated Cell Counters
  • Kits
  • Services

By Application

  • Regenerative Medicine & Therapy Development
    • Orthopedic & Musculoskeletal Spine Applications
    • Dermatology
    • Cardiovascular Applications
    • Central Nervous System Applications
    • Oncology
    • Diabetes
    • Other Applications
  • Drug Discovery & Development
  • Clinical Research

By End User

  • Biopharmaceutical & Biotechnology Companies
  • Research Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 35)
    4.1 Stem Cell Assays Market Overview
    4.2 Asia Pacific: Stem Cell Assays Market, By Instrument & Country
    4.3 Stem Cell Assays Market, By Type
    4.4 Geographical Snapshot of the Stem Cell Assays Market (By Major Countries)

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Availability of Funding for Stem Cell Research
                    5.2.1.2 Rising Incidence of Target Indications
                    5.2.1.3 Technological Advancements in Stem Cell-Based Research Instruments and Introduction of Novel Stem Cell Products
                    5.2.1.4 Growth of End-Use Industries
           5.2.2 Restraints
                    5.2.2.1 Ethical Issues Related to Embryonic Stem Cell Research
                    5.2.2.2 High Cost of Stem Cell Analysis Instruments and Reagents
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Economies
                    5.2.3.2 Emergence of Microfluidics in Stem Cell Research
                    5.2.3.3 High Growth Potential of Single Stem Cell Analysis Sequencing
           5.2.4 Challenges
                    5.2.4.1 Complexities Related to Antibody and Reagent Development
                    5.2.4.2 Survival of Small Players and New Entrants
    5.3 Technology Roadmap
           5.3.1 Microfabrication-Assisted Technologies
                    5.3.1.1 Microfluidics-Based Cell Trap Technology
                    5.3.1.2 Droplet-Based Microfluidic Technology
                    5.3.1.3 Microwell-Based Analysis Systems
           5.3.2 Advanced Technology
                    5.3.2.1 Bead-Based Multiplex Assays

6 Stem Cell Assays Market, By Type (Page No. - 49)
    6.1 Introduction
    6.2 Viability/Cytotoxicty Assays
    6.3 Isolation & Purification Assays
    6.4 Cell Identification Assays
    6.5 Proliferation Assays
    6.6 Differentiation Assays
    6.7 Function Assays
    6.8 Apoptosis Assays

7 Stem Cell Assays Market, By Cell Type (Page No. - 58)
    7.1 Introduction
    7.2 Adult Stem Cells
           7.2.1 Adult Stem Cells Market, By Type
                    7.2.1.1 Mesenchymal Stem Cells
                    7.2.1.2 Induced Pluripotent Stem Cells
                    7.2.1.3 Hematopoietic Stem Cells
                    7.2.1.4 Umbilical Cord Stem Cells
                    7.2.1.5 Neural Stem Cells
    7.3 Human Embryonic Stem Cells

8 Stem Cell Assays Market, By Product & Service (Page No. - 68)
    8.1 Introduction
    8.2 Instruments
           8.2.1 Instruments Market, By Type
                    8.2.1.1 Flow Cytometers
                    8.2.1.2 Microelectrode Arrays
                    8.2.1.3 Cell Imaging Systems
                    8.2.1.4 Automated Cell Counters
    8.3 Kits
    8.4 Services

9 Stem Cell Assays Market, By Application (Page No. - 78)
    9.1 Introduction
    9.2 Regenerative Medicine & Therapy Development
           9.2.1 Orthopedic & Musculoskeletal Spine Applications
           9.2.2 Dermatology
           9.2.3 Cardiovascular Applications
           9.2.4 Central Nervous System Applications
           9.2.5 Oncology
           9.2.6 Diabetes
           9.2.7 Other Applications
    9.3 Drug Discovery & Development
    9.4 Clinical Research

10 Stem Cell Assays Market, By End User (Page No. - 89)
     10.1 Introduction
     10.2 Biopharmaceutical & Biotechnology Companies
     10.3 Research Institutes

11 Global Stem Cell Assays Market, By Region (Page No. - 94)
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 UK
             11.3.3 France
             11.3.4 Spain
             11.3.5 Italy
             11.3.6 Switzerland
             11.3.7 Rest of Europe (RoE)
     11.4 Asia Pacific
             11.4.1 China
             11.4.2 Japan
             11.4.3 India
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World

12 Competitive Landscape (Page No. - 183)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
             12.3.1 Product Launches
             12.3.2 Partnerships & Agreements
             12.3.3 Acquisitions
             12.3.4 Expansions

13 Company Profiles (Page No. - 188)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     13.1 Thermo Fisher Scientific
     13.2 Merck
     13.3 GE Healthcare
     13.4 Bio-Rad Laboratories
     13.5 Promega Corporation
     13.6 Agilent Technologies
     13.7 Perkinelmer
     13.8 Miltenyi Biotec
     13.9 Cell Biolabs
     13.10 Hemogenix
     13.11 Stemcell Technologies
     13.12 Bio-Techne Corporation
     13.13 Cellular Dynamics International (CDI)

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 215)
     14.1 Industry Insights
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details


List of Tables (188 Tables)

Table 1 List of Diseases That Can Be Treated Using Stem Cells
Table 2 Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 3 Viability/Cytotoxicty Assays Market, By Region, 2016–2023 (USD Million)
Table 4 Isolation & Purification Assays Market, By Region, 2016–2023 (USD Million)
Table 5 Cell Identification Assays Market, By Region, 2016–2023 (USD Million)
Table 6 Proliferation Assays Market, By Region, 2016–2023 (USD Million)
Table 7 Differentiation Assays Market, By Region, 2016–2023 (USD Million)
Table 8 Function Assays Market, By Region, 2016–2023 (USD Million)
Table 9 Apoptosis Assays Market, By Region, 2016–2023 (USD Million)
Table 10 Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 11 Adult Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 12 Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 13 Mesenchymal Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 14 Induced Pluripotent Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 15 Hematopoietic Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 16 Umbilical Cord Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 17 Neural Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 18 Human Embryonic Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 19 Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 20 Stem Cell Assay Instruments Market, By Region, 2016–2023 (USD Million)
Table 21 Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 22 Flow Cytometers Market, By Region, 2016–2023 (USD Million)
Table 23 Microelectrode Arrays Market, By Region, 2016–2023 (USD Million)
Table 24 Cell Imaging Systems Market, By Region, 2016–2023 (USD Million)
Table 25 Automated Cell Counters Market, By Region, 2016–2023 (USD Million)
Table 26 Stem Cell Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 27 Stem Cell Assay Services Market, By Region, 2016–2023 (USD Million)
Table 28 Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 29 Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Region, 2016–2023 (USD Million)
Table 30 Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 31 Orthopedic & Musculoskeletal Spine Applications Market, By Region, 2016–2023 (USD Million)
Table 32 Dermatology Applications Market, By Region, 2016–2023 (USD Million)
Table 33 Cardiovascular Applications Market, By Region, 2016–2023 (USD Million)
Table 34 Central Nervous System Applications Market, By Region, 2016–2023 (USD Million)
Table 35 Oncology Applications Market, By Region, 2016–2023 (USD Million)
Table 36 Diabetes Applications Market, By Region, 2016–2023 (USD Million)
Table 37 Other Regenerative Medicine & Therapy Development Applications Market, By Region, 2016–2023 (USD Million)
Table 38 Stem Cell Assays Market for Drug Discovery & Development, By Region, 2016–2023 (USD Million)
Table 39 Stem Cell Assays Market for Clinical Research, By Region, 2016–2023 (USD Million)
Table 40 Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 41 Stem Cell Assays Market for Biopharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 42 Stem Cell Assays Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 43 Stem Cell Assays Market, By Region, 2016–2023 (USD Million)
Table 44 North America: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 45 North America: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 46 North America: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 47 North America: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 48 North America: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 49 North America: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 50 North America: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 51 North America: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 52 North America: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 53 Incidence & Prevalence of Target Diseases (2017)
Table 54 Timelines of Major Events in Stem Cell Research Policy (2011 - 2017)
Table 55 US: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 56 US: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 57 US: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 58 US: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 59 US: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 60 US: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 61 US: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 62 US: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 63 Canada: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 64 Canada: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 65 Canada: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 66 Canada: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 67 Canada: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 68 Canada: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 69 Canada: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 70 Canada: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 71 Europe: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 72 Europe: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 73 Europe: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 74 Europe: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 75 Europe: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 76 Europe: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 Europe: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 78 Europe: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 79 Europe: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 80 Germany: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 81 Germany: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 82 Germany: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 83 Germany: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 84 Germany: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 85 Germany: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 86 Germany: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 87 Germany: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 88 UK: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 89 UK: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 90 UK: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 91 UK: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 92 UK: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 93 UK: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 94 UK: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 95 UK: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 96 France: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 97 France: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 98 France: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 99 France: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 100 France: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 101 France: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 102 France: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 103 France: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 104 Spain: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 105 Spain: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 106 Spain: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 107 Spain: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 108 Spain: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 109 Spain: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 110 Spain: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 111 Spain: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 112 Italy: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 113 Italy: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 114 Italy: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 115 Italy: Stem Cell Assays Market, By Product & Service 2016–2023 (USD Million)
Table 116 Italy: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 117 Italy: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 118 Italy: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 119 Italy: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 120 Switzerland: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 121 Switzerland: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 122 Switzerland: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 123 Switzerland: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 124 Switzerland: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 125 Switzerland: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 126 Switzerland: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 127 Switzerland: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 128 RoE: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 129 RoE: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 130 RoE: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 131 RoE: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 132 RoE: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 133 RoE: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 134 RoE: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 135 RoE: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 136 Asia Pacific: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 137 Asia Pacific: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 138 Asia Pacific: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 139 Asia Pacific: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 140 Asia Pacific: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 141 Asia Pacific: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 142 Asia Pacific: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 143 Asia Pacific: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 144 Asia Pacific: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 145 China: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 146 China: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 147 China: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 148 China: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 149 China: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 150 China: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 151 China: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 152 China: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 153 Japan: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 154 Japan: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 155 Japan: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 156 Japan: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 157 Japan: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 158 Japan: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 159 Japan: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 160 Japan: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 161 India: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 162 India: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 163 India: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 164 India: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 165 India: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 166 India: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 167 India: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 168 India: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 169 RoAPAC: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 170 RoAPAC: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 171 RoAPAC: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 172 RoAPAC: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 173 RoAPAC: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 174 RoAPAC: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 175 RoAPAC: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 176 RoAPAC: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 177 RoW: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 178 RoW: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 179 RoW: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 180 RoW: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 181 RoW: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 182 RoW: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 183 RoW: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 184 RoW: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 185 Product Launches, 2014–2017
Table 186 Partnerships and Agreements, 2014–2017
Table 187 Acquisitions, 2014–2017
Table 188 Expansions, 2014–2017


List of Figures (41 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Stem Cell Assays Market, By Type, 2018 vs 2023 (USD Billion)
Figure 7 Stem Cell Assays Market, By Cell Type, 2018 vs 2023 (USD Billion)
Figure 8 Stem Cell Assays Market, By Product & Service, 2018 vs 2023 (USD Billion)
Figure 9 Stem Cell Assays Market, By Application, 2018 vs 2023 (USD Billion)
Figure 10 Stem Cell Assays Market, By End User, 2018 vs 2023 (USD Billion)
Figure 11 Stem Cell Assays Market, By Region, 2018 vs 2023 (USD Billion)
Figure 12 Availability of Funding for Stem Cell Research to Drive Market Growth During the Forecast Period
Figure 13 Flow Cytometers Accounted for the Largest Market Share in 2017
Figure 14 Isolation & Purification Assays to Register the Highest CAGR During the Forecast Period
Figure 15 Canada to Register the Highest CAGR During the Forecast Period
Figure 16 Stem Cell Assays Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 NIH Funding for Stem Cell Research in the Us, 2013 vs 2016 (USD Million)
Figure 18 Viability/Cytotoxicity Assays to Dominate the Market During the Forecast Period
Figure 19 Adult Stem Cells Segment to Dominate the Market During the Forecast Period
Figure 20 Mesenchymal Stem Cells Segment to Dominate the Market During the Forecast Period
Figure 21 Stem Cell Assay Instruments to Dominate the Market During the Forecast Period
Figure 22 Flow Cytometers to Dominate the Market During the Forecast Period
Figure 23 Regenerative Medicine & Therapy Development Segment to Dominate the Market During the Forecast Period
Figure 24 Biopharmaceutical & Biotechnology Companies to Dominate the Stem Cell Assays Market in 2023
Figure 25 North America to Dominate the Global Stem Cell Assays Market in 2018
Figure 26 North America: Stem Cell Assays Market Snapshot
Figure 27 Viability/Cytotoxicity Segment to Dominate the North American Stem Cell Assays Market in 2018
Figure 28 Europe: Stem Cell Assays Market Snapshot
Figure 29 Adult Stem Cells Segment to Dominate the European Stem Cell Assays Market in 2018
Figure 30 Asia Pacific: Stem Cell Assays Market Snapshot
Figure 31 Instruments Segment to Dominate the Asia Pacific Stem Cell Assays Market in 2018
Figure 32 RoW: Stem Cell Assays Market Snapshot
Figure 33 Regenerative Medicine & Therapy Development Segment to Dominate the RoW Stem Cell Assays Market in 2018
Figure 34 Market Share Analysis - 2016
Figure 35 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 36 Merck: Company Snapshot (2016)
Figure 37 GE Healthcare: Company Snapshot (2016)
Figure 38 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 39 Agilent Technologies: Company Snapshot (2017)
Figure 40 Perkinelmer: Company Snapshot (2016)
Figure 41 Bio-Techne Corporation: Company Snapshot (2017)

The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments.

The global stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, the market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The viability/cytotoxicity segment accounted for the largest market share of the global stem cell assay market in 2017. Factors driving the growth of this segment include the widespread use of viability/cytotoxicity assays in stem cell research activities.

By cell type, the market is segmented into adult stem cells and human embryonic stem cells. The adult stem cells segment accounted for the largest market share of the global stem cell assay market in 2017. Increasing research on adult stem cells and less stringent regulations are the key factors driving the growth of the adult stem cell market.

On the basis of product & service, the stem cell assay market is segmented into instruments, kits, and services. The instruments segment is estimated to account for the largest share of the global stem cell assay market during the forecast period. The growth of this segment is primarily attributed to the ongoing technological innovations in stem cell instruments and the rising number of stem cell research activities across the globe.

By application, the stem cell assay market is classified into regenerative medicine and therapy development; drug discovery and development; and clinical research. The regenerative medicine and therapy development segment is estimated to account for the largest share of the global stem cell assay market in the next five years. The large share of this segment can be attributed to the growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies.

On the basis of end user, the stem cell assay market is segmented into biopharmaceutical & biotechnology companies; and research institutes. The biopharmaceutical & biotechnology companies segment is estimated to account for the largest share of the global stem cell assay market. Growth in the number of biopharmaceutical and biotechnology companies globally, along with the increasing demand for novel cell therapies are driving the growth of this segment.

Stem Cell Assay Market

The global stem cell assay market is dominated by North America, followed by Europe. North America will continue to dominate the global stem cell assay market in the forecast period. Moreover, this region is also expected to witness the highest CAGR during the forecast period. North America’s large share and growth can be attributed to the favorable regulatory guidelines in the region, growing awareness about stem cell assays, the presence of a large number of market players, and increasing government investments in the field.
The factors such as the high degree of consolidation and a complex regulatory framework for the approval of new products may restrain the market’s growth to a certain extent.

Major industry players adopted product launches and partnerships & agreements to maintain and improve their position in the stem cell assay market. Thermo Fisher Scientific (US), Merck (Germany), GE Healthcare (US), Bio-Rad Laboratories (US), and Promega Corporation (US) have been identified as key players in this market. These companies have a broad product portfolio with comprehensive features and have also expanded their presence geographically. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo